ClearPoint Neuro, Inc. (CLPT) Stock

ClearPoint Neuro, Inc. (CLPT) is a Healthcare stock trading at $17.78 (as of 2026-06-18), with a market capitalization of $379.97M and a trailing P/E of -13.4. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

ClearPoint Neuro, Inc. is a U.S. medical device company that develops and commercializes systems for minimally invasive brain procedures guided by direct and intra-procedural MRI. Its products include the ClearPoint system and an MRI-based Neuro Navigation suite, serving clinical users performing procedures such as deep brain stimulation electrode insertion, biopsies, and image-guided delivery of therapies.

Valuation — source: SEC EDGAR (first-party)
Price	$17.78
Market Cap	$379.97M
P/E Ratio	-13.4
EV / EBITDA	-16.2
Price / Book	21.39
Price / Sales	9.92
DCF Value (model)	$-14.10
DCF Upside vs Price	-179.3%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$36.97M
Net Margin	-69.1%
Return on Equity	-154.3%
Debt / Equity	2.63
Current Ratio	5.79
Revenue Growth (YoY)	17.8%
EPS Growth (YoY)	28.6%
FCF Growth (YoY)	165.0%

Financial Health — source: SEC EDGAR
Altman Z-Score	1.64 (distress)

Valuation vs Sector & Industry
Stock P/E	-13.4
Sector P/E (Healthcare)	21.0
Industry P/E (Medical Equipment)	31.7
vs Sector	-164.1%
vs Industry	-142.3%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	VANGUARD GROUP INC ($24.17M)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Medical Equipment
CEO	Joseph Michael Burnett
Employees	115
Country	US
IPO Date	2012-05-22

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.